scholarly journals Stepwise intensification of insulin therapy in Type 2 diabetes management—exploring the concept of the basal‐plus approach in clinical practice

2013 ◽  
Vol 30 (3) ◽  
pp. 276-288 ◽  
Author(s):  
D. R. Owens
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Practice ◽  
Insulin Therapy ◽  
Diabetes Management

scholarly journals SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

2018 ◽  
Vol 9 (5) ◽  
pp. 1757-1773 ◽  
Author(s):  
John Wilding ◽  
Kevin Fernando ◽  
Nicola Milne ◽  
Marc Evans ◽  
Amar Ali ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Practice ◽  
Diabetes Management ◽  
Sglt2 Inhibitors

Addition of exenatide to insulin therapy in individuals with type 2 diabetes in UK routine clinical practice

2012 ◽  
Vol 29 (2) ◽  
pp. 61-64 ◽  
Author(s):  
Hermione C Price ◽  
Catherine Gorst ◽  
Usha Ayyagari ◽  
Jonathan Levy ◽  
Rury R Holman
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Practice ◽  
Insulin Therapy ◽  
Routine Clinical Practice

Walking: a matter of quantity and quality physical activity for type 2 diabetes management

2008 ◽  
Vol 33 (4) ◽  
pp. 797-801 ◽  
Author(s):  
Steven T. Johnson ◽  
Normand G. Boulé ◽  
Gordon J. Bell ◽  
Rhonda C. Bell
Keyword(s):  
Physical Activity ◽  
Type 2 Diabetes ◽  
Clinical Practice ◽  
Health Outcomes ◽  
Walking Speed ◽  
Diabetes Management ◽  
Health Benefit ◽  
Current Clinical Practice ◽  
Steps Per Day

Walking is often prescribed as a mode of physical activity for people with type 2 diabetes (T2D). We and others have found that although people with T2D may increase the amount that they walk (e.g., more steps per day), improvements in key health outcomes are rarely achieved. We agree that walking is an acceptable approach for people with T2D to meet current clinical practice guidelines, but consideration of both the total number of daily steps and the walking speed of a portion of those total daily steps are necessary to gain health benefit.

scholarly journals Psychological Insulin Resistance (PIR) Among Type 2 Diabetes Patients at Public Health Clinics in Federal Territory of Malaysia

2020 ◽  
Vol 10 (2) ◽  
Author(s):  
Nur Azmiah Z ◽  
Zulkarnain AK ◽  
Tahir A
Keyword(s):  
Public Health ◽  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Insulin Treatment ◽  
Diabetes Management ◽  
Cross Sectional ◽  
Health Clinics ◽  
Public Health Clinics

Introduction: Insulin has been viewed as a treatment option of last resort in type 2 diabetes management. The decision to start insulin therapy is often diffi cult. Patients are usually reluctant to begin insulin and many cases delay the initiation of insulin therapy. The aim of this study is to determine the magnitude of insulin refusal or recognize as psychological insulin resistance (PIR) and to identify its predictors. Materials and Methods: This is a cross-sectional study and data was collected from two primary public health clinics in Kuala Lumpur and Putrajaya. The study sample consisted of 404 insulin naive patients with type 2 diabetes. A self-administered questionnaire was used to obtain demographic and clinical information. Results: Fifty-one percent of patients with type 2 diabetes were found to be unwilling to take insulin. Regression analysis revealed that females were 2.7 times more likely to resist insulin treatment compared to males and those with uncontrolled diabetes were 1.8 times more likely to resist insulin treatment compared to controlled diabetics. Patients will refuse insulin if they perceived their diabetes worsen with insulin use. After controlling for other attitudinal belief factors in the model, an increase in one unit of perceived disease severity will increase the likelihood of PIR around 2 times. Conclusion: Several misconceptions regarding insulin therapy were identifi ed and specifi c education intervention is recommended for successful transition to insulin therapy.

Sign in / Sign up

Export Citation Format

Share Document